Boston Scientific Vercise Deep Brain Stimulation System Receives CE Mark Approval

The Boston Scientific Corporation (NYSE: BSX ) Vercise Deep Brain Stimulation (DBS) System has received CE Mark approval for the treatment of intractable primary and secondary dystonia, a neurological movement disorder characterized by involuntary muscle contractions. Dystonia affects more than 500,000 people across Europe, including children and adults. It is